Patent details

Basic Information

Publication number:

EP2700651

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131854226

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Compositions monovalent for CD28 binding and methods of use

French Title of Invention:

Compositions monovalentes pour la liaison au CD28 et procédés d'utilisation

German Title of Invention:

Zur Bindung von CD28 monovalente Zusammensetzungen und Verfahren zur Verwendung

SPC Number:

Dates

Filing date:

17/07/2009

Grant date:

10/04/2019

EP Publication Date:

26/02/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/04/2019

EP B1 Publication Date:

10/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/07/2022

Expiration date:

17/07/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/04/2019

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Name:

Domantis Limited

Address:

980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom (GB)

Agent

Name:

MARKS & CLERK LLP

From:

30/04/2019

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

Ignatovich, Olga

Address:

United Kingdom (GB)

2

Name:

Suchard, Suzanne J.

Address:

United States (US)

3

Name:

Holmes, Steve

Address:

United Kingdom (GB)

4

Name:

Nadler, Steven G.

Address:

United States (US)

5

Name:

McKinnon, Murray

Address:

United States (US)

6

Name:

Grant, Steve

Address:

United Kingdom (GB)

7

Name:

Plummer, Christopher

Address:

United Kingdom (GB)

8

Name:

Classon, Brendan

Address:

United States (US)

Priority

1

Priority Number:

82078 P

Priority Date:

18/07/2008

Priority Country:

United States (US)

2

Priority Number:

162121 P

Priority Date:

20/03/2009

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28;

Publication

European Patent Bulletin

Issue number:

201915

Publication date:

10/04/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

12/07/2021

Last Annual Fee Paid Number:

13

Last Annual Fee Paid Amount:

180 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56
03/05/2019	Outgoing Correspondence	1
30/04/2019	Power Of Attorney	1